Delivery Order SPE2D021DA002-SPE2D324F231L

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB medical supply contract vehicle. The $2,817.45 award is for the delivery of YF-VAX 1 dose vials, with a period of performance through September 9, 2024. DMS Pharmaceutical Group is a key supplier of pharmaceuticals and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing...
The U.S. Defense Logistics Agency (DLA) awarded a $1,126.98 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of YF-VAX 1-dose vials and has a completion date of June 26, 2024. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide range of...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,253.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 DOSE VIALS and has a period of performance through June 6, 2024. DMS Pharmaceutical Group is an experienced government contractor that provides a wide range of branded and generic pharmaceutical products, biologics, and medical supplies to support the recurring...
This federal contract award of $2,817.45 is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of October 4, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.47 firm fixed-price delivery order is for the procurement of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,783.55 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a period of performance through April 4, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award, valued at $5,634.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm-fixed-price delivery order for the supply of YF-VAX 1-dose vials, with a performance period through October 10, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,670.13 firm fixed-price delivery order contract is for the provision of YF-VAX 1 dose vials, which are specialized pharmaceutical products. The contract has an ultimate completion date of February 14, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,783.55, is for the delivery of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F231L
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $2,954.65 firm fixed-price delivery order contract is for the supply of a single pharmaceutical product, the YF-VAX 1 dose vial, with a period of performance through August 30, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA, valued up to $499,999,999, which provides a wide range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation. Through this contract and other prime vendor agreements, DMS Pharmaceutical Group supplies a comprehensive array of medications, including branded and generic prescription drugs, biologics, and medical consumables, to the Department of Defense and Department of Veterans Affairs.

Generated 11/28/24, 9:02 AM